Genetics of neonatal hyperinsulinism

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 82, Issue 2, 2000, Pages

  Glaser, Benjamin ^a   Thornton, Paul ^b   Otonkoski, Timo ^c   Junien, Claudine ^d  

^a HEBREW UNIVERSITY   (Israel)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF HELSINKI   (Finland)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

ATP sensitive potassium channel; Hyperinsulinism; Hypoglycaemia; Sulphonylurea receptor

Indexed keywords

GLUCOKINASE; GLUTAMATE DEHYDROGENASE; INSULIN; POTASSIUM CHANNEL;

ARTICLE; CELL FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HUMAN; HYPERINSULINISM; HYPOGLYCEMIA; INSULIN RELEASE; NEWBORN; PANCREAS ISLET BETA CELL; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL;

EID: 0034104609     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.82.2.f79     Document Type: Article

References (51)

1. 1 Otonkoski T, Ammala C, Huopio H, et al. A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland. Diabetes 1999;48:408-15.
2. 2 Bruining GJ. Recent advances in hyperinsulinism and the pathogenesis of diabetes mellitus. Curr Opin Pediatr 1990;2:758-65.
3. 3 Mathew PM, Young JM, Abu OY, et al. Persistent neonatal hyperinsulinism. Clin Pediatr (Phila) 1988;27:148-51.
4. 4 Virsolvy-Vergine A, Salazar G, Sillard R, Denoroy L, Mutt V, Bataille D. Endosulfine, endogenous ligand for the sulphonylurea receptor: isolation from porcine brain and partial structural determination of the alpha form. Diabetologia 1996;39:135-41.
5. 5 Heron L, Virsolvy A, Peyrollier K, et al. Human alpha-endosulfine, a possible regulator of sulfonylurea-sensitive KATP channel: molecular cloning, expression and biological properties. Proc Natl Acad Sci U S A 1998;95:8387-91.
6. 6 Woo D, Scopes JW, Polak JM. Idiopathic hypoglycaemia in sibs with morphological evidence of nesidioblastosis of the pancreas. Arch Dis Child 1976;51:528-31.
7. 7 Moreno LA, Turck D, Gottrand F, Fabre M, Manouvrier HS, Farriaux JP. Familial hyperinsulinism with nesidioblastosis of the pancreas: further evidence for autosomal recessive inheritance. Am J Med Genet 1989;34:584-6.
8. 8 Woolf DA, Leonard JV, Trembath RC, Pembrey ME, Grant DB. Nesidioblastosis: evidence for autosomal recessive inheritance. Arch Dis Child 1991;66:529-30.
9. 9 Becker K, Wendel U, Przyrembel H, Tsotsalas M, Müntefering H, Bremer HJ. Beta cell nesidioblastosis. Eur J Pediatr 1978;127:75-89.
10. 10 Schwartz SS, Rich BH, Lucky AW, et al. Familial nesidioblastosis: severe neonatal hypoglycemia in two families. Pediatrics 1979;95:44-53.
11. 11 Rahier J, Falt K, Muntefering H, Becker K, Gepts W, Falkmer S. The basic structural lesion of persistent neonatal hypoglycaemia with hyperinsulinism: deficiency of pancreatic D cells or hyperactivity of B cells? Diabetologia 1984;26:282-9.
12. 12 Horev Z, Ipp M, Levey P, Daneman D. Familial hyperinsulinism: successful conservative management. J Pediatr 1991;119:717-20.
13. 13 Falkmer S, Sovik O, Vidnes J. Immunohistochemical, morphometric, and clinical studies of the pancreatic islets in infants with persistent neonatal hypoglycemia of familial type with hyperinsulinism and nesidioblastosis. Acta Biologica et Medica Germanica 1981;40:39-54.
14. 14 Hammersen G, Trefz FR, Schmidt H. Familial nesidioblastosis. J Pediatr 1980;96:778.
15. 15 Glaser B, Phillip M, Carmi R, Lieberman E, Landau H. Persistent hyperinsulinemic hypoglycemia of infancy ("nesidioblastosis"): autosomal recessive inheritance in 7 pedigrees. Am J Med Genet 1990;37:511-15.
16. 16 Thornton PS, Sumner AE, Ruchelli ED, Spielman RS, Baker L, Stanley CA. Familial and sporadic hyperinsulinism: histopathologic findings and segregation analysis support a single autosomal recessive disorder. J Pediatr 1991;119:721-4.
17. 17 Glaser B, Chiu KC, Anker R, et al. Familial hyperinsulinism maps to chromosome 11p14-15.1, 30 cM centromeric to the insulin gene. Nat Genet 1994;7:185-8.
18. 18 Thomas PM, Cote GJ, Hallman DM, Mathew PM. Homozygosity mapping, to chromosome 11p, of the gene for familial persistent hyperinsulinemic hypoglycemia of infancy. Am J Hum Genet 1995;56:416-21.
19. 19 Aguilar-Bryan L, Nichols CG, Wechsler SW, et al. Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 1995;268:423-6.
20. 20 Thomas PM, Cote GJ, Wohllk N, et al. Mutations in the sulfonylurea receptor gene in familial hyperinsulinemic hypoglycemia of infancy. Science 1995;268:426-9.
21. ATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 1995;270:1166-70.
22. 22 Dunne MJ, Kane C, Shepherd RM, et al. Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med 1997;336:703-6.
23. 23 Glaser B, Chiu KC, Liu L, et al. Recombinant mapping of the familial hyperinsulinism gene to an 0.8 cM region on chromosome 11p15.1 and demonstration of a founder effect in Ashkenazi Jews. Hum Mol Genet 1995;4:879-86.
24. IR6.2 also leads to familial persistent hyperinsulinemic hvpoglycemia of infancy. Hum Mol Genet 1996;5:1809-12.
25. IR6.2, is associated with familial hyperinsulinism. Diabetes 1997;46:1743-8.
26. + channels. Endocr Rev 1999;20:101-35.
27. 27 Thomas PM, Wohllk N, Huang E, et al. Inactivation of the first nucleotide-binding fold of the sulfonylurea receptor, and familial persistent hyperinsulinemic hypoglycemia on infancy. Am J Hum Genet 1996;59:510-8.
28. 28 Nestorowicz A, Wilson BA, Schoor KP, et al. Mutations in the sulfonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews. Hum Mol Genet 1996;5:1813-22.
29. 29 Nestorowicz A, Glaser B, Wilson BA, et al. Genetic heterogeneity in familial hyperinsulinism. Hum Mol Genet 1998;7:1119-28.
30. 30 de Lonlay-Debeney P, Poggi-Travert F, Fournet JC, et al. Clinical features of 52 neonates with hyperinsulinism. N Engl J Med 1999;340:1169-75.
31. 31 Nichols CG, Shyng S-L, Nestorowicz A, et al. Adenosine diphosphate as an intracellular regulator of insulin secretion. Science 1996;272:1785-7.
32. 32 Shyng SL, Ferrigni T, Shepard JB; et al. Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancy. Diabetes 1998;47:1145-51.
33. 33 Dunne MJ, Cosgrove KE, Shepherd RM, Ammala C. Potassium channels, sulphonylurea receptors and control of insulin release. Trends Endocrinol Metab 1999;10:146-52.
34. ATP, channel subunits. Neuron 1997;18:827-38.
35. 35 Miki T, Tashiro F, Iwanaga T, et al. Abnormalities of pancreatc islets by targeted expression of a dominant-negative Katp channel. Proc Natl Acad Sci U S A 1997;94:1 1969-73.
36. 36 Zammarchi E, Filippi L, Novembre E, Donati MA. Biochemical evaluation of a patient with a familial form of leucine-sensitive hypoglycemia and concomitant hyperammonemia. Metabolism 1996;45:957-60.
37. 37 Weinzimer SA, Stanley CA, Berry GT, Yudkoff M, Tuchman M, Thornton PS. A syndrome of congenital hyperinsulinism and hyperammonemia. J Pediatr 1997;130:661-4.
38. 38 Stanley CA, Lieu YK, Hsu BY, et al. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 1998;338:1352-7.
39. 39 Glaser B, Kesavan P, Heyman M, et al. Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med 1998;338:226-30.
40. 40 Ipp E, Sinai Y, Forster B, et al. A glucose reduction challenge in the differential diagnosis of fasting hypoglycemia: a two-center study. J Clin Endocrinol Metab 1990;70:711-17.
41. 41 Glaser B, Hirsch HJ, Landau H. Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy. J Pediatr 1993;123:644-50.
42. 42 Glaser B, Furth J, Stanley CA, et al. Intragenic single nucleotide polymorphism haplotype analysis of SUR1 mutations in familial hyperinsulinism. Hum Mutat 1999;14:23-9.
43. 43 Witchel SF, Bhamidipati DK, Hoffman EP, Cohen JB. Phenotypic heterogeneity associated with the splicing mutation in congenital adrenal hyperplasia due to 21-hydroxylase deficiency [see comments], J Clin Endocrinol Metab 1996;81:4081-8.
44. 44 Goossens A, Gepts W, Saudubray JM, et al. Diffuse and focal nesidioblastosis. A clinicopathological study of 24 patients with persistent neonatal hyperinsulinemic hypoglycemia. Am J Surg Pathol 1989;13:766-75.
45. 45 de Lonlay P, Fournet JC, Rahier J, et al. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest 1997;100:802-7.
46. 46 Patel P, O'Rahilly S, Buckle V, Nakamura Y, Turner RC, Wainscoat JS. Chromosome 11 allele loss in sporadic insulinoma. J Clin Pathol 1990;43:377-8.
47. 47 Ryan FD, Devaney D, Joyce C, et al. Hyperinsulinism: the molecular aetiology of focal disease. Arch Dis Child 1998;79:445-7.
48. 48 Verkarre V, Fournet JC, de Lonlay P, et al. Paternal mutation of the sulfonylurea receptor (SURI) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest 1998;102:1286-91.
49. 49 Glaser B, Ryan F, Donath M, et al. Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea receptor gene. Diabetes 1999;48:1652-7.
50. 50 Leibowitz G, Glaser B, Higazi AA, Salameh M; Cerasi E, Landau H. Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: incidence of diabetes mellitus and persistent β-cell dysfunction at long-term follow-up. J Clin Endocrinol Metab 1995;80:386-92.
51. 51 Dubois J, Brunelle F, Touati G, et al. Hyperinsulinism in children: diagnostic value of pancreatic venous sampling correlated with clinical, pathological and surgical outcome in 25 cases. Pediatr Radiol 1995;25:512-16.